![](/img/cover-not-exists.png)
864 Close Monitoring of CRP and Fecal Calprotectin is Able to Predict Clinical Relapse in Patients With Crohn's Disease in Remission After Infliximab Withdrawal. a Sub-Analysis of the Stori Study
Nicolas de Suray, Julia Salleron, Gwenola Vernier-Massouille, Jean-Charles Grimaud, Yoram Bouhnik, David Laharie, Jean-Louis Dupas, Hélène Pillant-Le Moult, Laurence Picon, Michel Veyrac, Mathurin FlaVolume:
142
Year:
2012
Language:
english
DOI:
10.1016/s0016-5085(12)60560-5
File:
PDF, 68 KB
english, 2012